India to Germany: Bortezomib Export Trade Route

The India to Germany Bortezomib corridor is one of India's established pharmaceutical export routes, with 82 shipments documented worth a combined $821.9K USD. The route is dominated by FRESENIUS KABI ONCOLOGY LIMITED, which alone accounts for roughly 69% of all export value, reflecting the consolidated nature of India's bortezomib manufacturing sector.

Across 4 active suppliers, the average shipment value stands at $10.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 76% of all shipments, consistent with bortezomib's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 32 days port-to-port. The route has recorded an annual growth rate of 25.7%, placing it at rank #20 among India's top bortezomib export destinations globally.

On the import side, key buyers of Indian bortezomib in Germany include FRESENIUS KABI DEUTSCHLAND GMBH, V P G, FRESENIUS KABI DEUTSCHLAND GMBH and 2 others. FRESENIUS KABI DEUTSCHLAND GMBH is the single largest importer with 55 shipments valued at $514.9K USD.

India's bortezomib exports to Germany are driven primarily by a handful of large-scale manufacturers. FRESENIUS KABI ONCOLOGY LIMITED with 65 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 4 active exporters signals a competitive but concentrated market — buyers in Germany benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — FRESENIUS KABI ONCOLOGY LIMITED, VENUS REMEDIES LIMITED, FRESENIUS KABI ONCOLOGY LIMITED — together account for 94% of total trade value on this route. The average shipment value of $10.0K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as bortezomib fresenius kabi injection 3.5m and bortezomib fresenius kabi injection 3.5m , suggesting that buyers in Germany tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, FRESENIUS KABI DEUTSCHLAND GMBH is the largest importer with 55 shipments worth $514.9K USD — representing 63% of all bortezomib imports from India on this route.